SOFINICLINE (ABT-894 ) for attention-deficit/hyperactivity disorder

3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3, 6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-def icit/hyperactivity disorder.

Saved in:
Bibliographic Details
Main Authors GARIMELLA TUSHAR S, BAIN EARLE E, AWNI WALID M, ABI-SAAB WALID M, DUTTA SANDEEP, SALTARELLI MARIO D
Format Patent
LanguageChinese
English
Published 11.05.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3, 6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-def icit/hyperactivity disorder.
Bibliography:Application Number: CN200980120758